Patent Yard Sign in
Canadian application, no grantCanada

Serine o-acetyltransferase

CA 2713200 A1 · Owner: Falco, Saverio C. · Inventors: Falco, Saverio C.; Allen, Stephen; Tarczynaski, Mitchell

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention relates to an isolated nucleic acid fragment encoding a serine O--acetyltransferase. The invention also relates to the construction of a recombinant DNA , construct encoding all or a portion of the serine O-acetyltransferase in , sense or antisense , orientation, wherein expression of the recombinant DNA construct results in production of , altered levels of the serine O-acetyltransferase in a transformed host cell.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 21, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 21, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 21, 2002
GrantedNo grant recorded
Term endedMay 21, 2022
Patent numberCA 2713200 A1
Classification (IPC)C12N15/54 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedMay 21, 2002Term endedMay 21, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.